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Abstract 
Purpose: To investigate the effect of Fufang-Huanglu Oral Liquid (HOL) on hepatitis jaundice in mice. 
Methods: A total of 72 mice were divided into 6 groups (n = 12): normal group, control group (model 
group), positive-treated group, and 3 HOL treatment groups (7.5, 15 and 30 mL/kg). Mice in normal and 
control groups received normal saline (20 mL/kg) orally, while positive and HOL-treated mice were 
orally administered Huganning tablets (1.0 g/kg) and HOL (7.5, 15 and 30 mL/kg), respectively. After 8 
days, all mice (except normal group) were orally administered α-naphthylisothiocyanate (ANIT, 100 
mg/kg) to induce hepatitis jaundice, and sacrificed 2 days after drug administration. Serum GPT, GOT 
and TNF-α, as well as liver index, MDA, SOD and lipid profiles were determined. 
Results: The results showed that HOL, at all doses, significantly decreased liver index, serum GPT, 
serum SGOT and serum TNF-α (p < 0.01). HOL also significantly decreased MDA, total cholesterol, TC 
and triglycerides, TG (p < 0.01), but increased liver SOD (p < 0.01). Histological results indicate that 
HOL ameliorated liver injury induced by ANIT.  
Conclusion: These results showed that HOL possesses significant hepatoprotective effects against 
liver injury.  
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It is well known that the liver is a vital intra-
abdominal organ which performs important 
biological functions such as bile secretion, 
synthesis of plasma proteins and lipid 
biosynthesis [1,2]. It is known that liver injury 
may arise from excessive alcohol intake, as well 
as exposure to various toxins and environmental 
pollutants. These risk factors are responsible for 
increasing incidence of liver injury, which may 
degenerate to severe liver diseases such as 
hepatitis, cirrhosis, and even liver cancers [3,4]. 
Thus, it is necessary to develop more potent 
drugs for treatment of liver injury-related 
diseases. 
 
Fufang-Huanglu Oral Liquid (HOL), a herbal 
prescription in traditional Chinese medicines, is 
clinically used for treatment of hepatitis jaundice 
(icteric), chronic hepatitis and hepatitis C [5,6]. 
HOL is composed of Cotinus coggygria, 
Schisandra chinensis, Sedum sarmentosum, 
Fructus gardenia, Fructus lycii, and Fructus 
jujubae [5]. Recently, HOL was developed as an 
effective Chinese patent medicine by the 371 
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Hospital of Chinese People's Liberation Army. 
However, there are no animal studies so far on 
the health benefits of HOL. The present study 
was aimed at investigating the effect of HOL on 
ANIT-induced hepatitis jaundice in mice, with a 
view to establishing a basis for its clinical 






Male specific pathogen Free (SPF) KM mice 
(weighing 18 – 21 g) were purchased from the 
Shandong Lukang Pharmaceutical Co., Ltd 
(certificate no. 37009200000791) (Jinan, China). 
All animals were housed in a room with natural 
lighting at relative temperature of 20 – 25 °C and 
humidity of 40 – 60 %. They were allowed free 
access to food and water. All the animal 
protocols used were according to the 
international standard protocols for the use of 
laboratory animals [7], and were approved by 
Animal Care and Use Committee of The 371 
Hospital of Chinese People's Liberation Army 
(no. an-2015-245#). 
 
Chemicals and reagents 
 
Fufang-Huanglu Oral Liquid (HOL) was obtained 
from the 371 Hospital of Chinese People's 
Liberation Army (Batch No. 20150420, Xinxiang, 
China); Huganning tablets were used as the 
positive drug and were purchased from the 
Guangdong Baodan Pharmaceutical Co., Ltd 
(Batch No. 20150701, Huizhou, China). Mouse 
serum glutamic-oxaloacetic transaminase 
(SGOT) Elisa kit (Batch No. 23037906), Mouse 
serum glutamate pyruvate (SGPT) Elisa kit 
(Batch No. 23037907), and other Elisa kits were 
purchased from the Beijing Dongge (DG) Boye 
Biotech. (Beijing, China). ANIT was product of 
Aladdin Chemical Reagents Co. (Shanghai, 
China). 
 
Animal grouping and experimental protocols 
 
A total of 72 mice were divided into 6 groups 
(n=12): normal group, control group (model 
group), positive treated group, and 3 HOL treated 
groups (7.5, 15 and 30 ml/kg body weight). The 
mice in normal and control groups were treated 
orally with normal saline (20 ml/kg body weight). 
The commercial drug, Huganning tablets 
possess definite curative effect on hepatitis [8]. 
Mice in the positive group were treated orally 
with Huganning tablets (1.0 g/kg body weight). 
The HOL-treated mice were orally administered 
with HOL (7.5, 15 and 30 mL/kg). After 8 days 
treatment, all mice (except the normal group) 
were orally administered ANIT (100 mg/kg) to 
prepare the hepatitis jaundice mice model. Then, 
after 2 days of drug administration, the mice 
were sacrificed by decollation after collection of 
blood samples from the aorta abdominals under 
anesthesia (phentobarbital sodium, 45 mg/kg 
body weight through intraperitoneal injection). 
The blood samples were used for assay of 
SGPT, SGOT, and TNF-α, while liver tissues 
were dissected out and used for determination of 
liver index, pathological changes, MDA, SOD, TC 
and TG. 
 
Determination of serum levels of SGPT, 
SGOT and TNF-α 
 
Blood samples were centrifuged at 3000 rpm for 
10 min to obtain the serum samples, and then 
the serum levels of SGPT, SGOT and TNF-α 
were determined by using commercial ELISA kits 
according to the manufactures’ instructions.  
 
Determination of MDA, SOD, TC and TG in 
liver tissues 
 
Liver tissues were homogenized and centrifuged 
at 3000 for 20 min, and then commercial ELISA 
kits were used to determine the levels of MDA, 
SOD, TC and TG in the liver homogenate 
according to the manufactures’ instructions.  
 
Histological examination of liver tissues 
 
Fresh liver tissue samples from each group were 
fixed in 10 % neutral formalin and processed for 
light microscopy in line with standard protocols 
(dehydration, embedding in wax, sectioning, and 
staining with H&E). The liver sections were 
examined in a microscope (Olympus CX22LED, 




Data are represented as mean ± SD (N = 12), 
and statistical analysis was carried out using two-
tailed Student’s t-test with the SPSS 17.0 (SPSS 







Results of liver index are shown in Table 1. 
Compared to the normal mice, the liver index 
values of control mice were significantly 
increased by treatment with ANIT (100 mg/kg 
body weight; p < 0.01). Furthermore, the results 
also showed that treatment with positive drug (1 
g/kg body weight, p < 0.01) and HOL (30, 15 and 
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7.5 mL/kg body weight; p < 0.01, p < 0.05 and p 
< 0.01, respectively) led to significant decreases 
in liver index when compared with the control 
mice. 
 
Effect of HOL on SGPT and SGOT levels 
 
Results of the effect of HOL on the serum levels 
of GPT and GOT are shown in Table 1. After 
treatment with ANIT (100 mg/kg body weight), 
SGPT and SGOT were significantly increased in 
the control mice relative to mice in the normal 
group (p < 0.01 and p < 0.01, respectively). In 
addition, the results revealed that HOL at the 
doses of 30, 15 and 7.5 ml/kg body weight 
significantly reduced both SGPT (p < 0.01) and 
SGOT (p < 0.01) levels. 
 
Effect of HOL on the serum level of TNF-α 
 
Effects of HOL on the serum level of TNF-α are 
shown in Table 1. Serum TNF-α was significantly 
increased in control mice (p < 0.01), compared 
with the normal mice. The positive drug 
(Huganning tablets) at the dose of 1 g/kg body 
weight significantly decreased serum level of 
TNF-α (p < 0.01). Interestingly, compared to the 
control mice, the results indicated that serum 
level of TNF-α were significantly decreased by 
treatment with HOL at the doses of 30, 15 and 
7.5 mL/kg (p < 0.01). 
 
Effect of HOL on liver levels of TC and TG 
 
As shown in Table 1, TG and TC levels in control 
mice were significantly higher than that of normal 
mice (p < 0.01). The results indicated that the 
positive drug (1 g/kg body weight) and HOL (30, 
15 and 7.5 mL/kg) brought about significant 
decreases in the levels of TC (p < 0.01) and TG 
in liver tissues (p < 0.01). 
 
Effect of HOL on levels of MDA and SOD in 
liver tissues 
 
The MDA level in control mice was significantly 
increased (p < 0.01), whereas SOD level in the 
same group significantly decreased (p < 0.01) 
when compared to the normal mice (Table 1). 
Treatment with HOL significantly reversed this 
trend, by significantly reducing MDA levels while 
bringing about significant increases in SOD at 
the three doses used (p < 0.01). 
 
Effect of HOL on liver histology 
 
As shown in Figure 1, no obvious pathological 
changes were evident in the liver sections of 
normal mice. In contrast, for the control mice, the 
hepatic lobule boundary was unclear, and the 
arrangement of the hepatocytes appeared 
distorted. In addition, local necrosis and severe 
inflammatory cell infiltration were observed. 
Compared with the control mice, HOL treatment 
(30, 15 and 7.5 mL/kg) significantly reversed the 
liver injury, just like in the positive drug-treated 
mice. For example, a clear hepatic lobule 
boundary could be seen, and the local necrosis 
and severe inflammatory cell infiltration were 
obviously decreased In addition, abundant 
regenerated liver cells could be found in the liver 




In this investigation, the effects of HOL on 
hepatitis jaundice induced by ANIT in mice were 
studied for the first time. Previous reports 
demonstrated that traditional Chinese medicines 
(TCM) are important resources for discovery of 
useful potential drugs with low side-effects, for 
treating various diseases. Currently, many 
studies have consistently demonstrated that 
TCMs are especially suitable agents for 
protection of liver function and treatment of liver 
diseases [9,10]. 
 
The model of ANIT-induced hepatitis jaundice 
mice is a useful tool for investigating the 
hepatoprotective effects of candidate drugs 
[11,12]. The current study successfully 
established the model by using ANIT, and 
demonstrated that HOL could decrease liver 
index and degree of liver injury in the 
experimental model mice, indicating that HOL 
possesses potential hepatoprotective effects. 
Elevated SGPT and SGOT are two characteristic 
markers for hepatic injury [2,13,14]. In this study, 
the levels of SGPT and SGOT were sharply 
increased after ANIT treatment. Interestingly and 
importantly, HOL treatment significantly 
decreased the elevated SGPT and SGOT levels. 
TG and TC are another two biomarkers of liver 
function [8,15,16]. Similar to SGPT and SGOT, 
TC and TG were found to be significantly 
increased in the model mice, whereas the HOL 
treatment reversed the increases. These results 
indicate that HOL has the potential to protect the 
liver. TNF-α is a notable marker for inflammatory 
reactions in liver tissues [2,17]. The results of the 
present study revealed that HOL caused 
significant decreases in TNF-α levels. MDA, the 
major end products of lipid peroxidation, is 
considered a marker of oxidative stress and one 
of the indicators of liver injury [9,18]. 
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Table 1: Effects of HOL on liver index and on serum levels of SGPT, SGOT, TNF-α, TC, TG, MDA and SOD of mice with jaundice hepatitis induced by ANIT 
 
Group Normal Control Positive HOL-H HOL-M HOL-L 
Liver index 
(mg/g) 50.66 ± 2.01** 63.50 ± 6.44 52.02 ± 3.15** 53.03 ± 6.54** 54.40 ± 5.85* 53.35 ± 4.78** 
SGPT (U/L) 9.93 ± 0.72** 27.35 ± 1.58 10.52 ± 1.05** 17.26 ± 1.81** 11.57 ± 1.24** 10.05 ± 0.89** 
SGOT (U/L) 6.71 ± 1.03** 16.04 ± 1.09 6.12 ± 0.64** 7.01 ± 0.56** 5.74 ± 0.61** 6.93 ± 0.89** 











TC (mmol/L) 1.53 ± 0.24** 2.54 ± 0.21 1.59 ± 0.25** 1.74 ± 0.25** 1.60 ± 0.19** 2.01 ± 0.16** 
TG (mmol/L) 0.53 ± 0.087** 0.89 ± 0.071 0.61 ± 0.067** 0.67 ± 0.065** 0.66 ± 0.070** 0.61 ± 0.078** 
MDA (nmol/L) 2.86 ± 0.20** 3.53 ± 0.21 2.88 ± 0.17** 3.26 ± 0.10** 3.10 ± 0.13** 2.89 ± 0.10** 
SOD (U/mL) 51.00 ± 5.25** 25.04 ± 2.03 47.33 ± 4.38** 28.81 ± 2.57** 38.03 ± 5.52** 46.77 ± 4.72** 
HOL-H, HOL-M and HOL-L means the high, middle and low doses of HOL. Data are expressed as mean ± SD (n = 12), *p < 0.05, **p < 0.01, compared with 
the control group 
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    Figure 1: Results of the pathological examination in liver tissues 
 
In addition, SOD is an antioxidant enzyme 
recognized as an inhibitor of oxidative stress 
[19,20]. HOL treatment significantly decreased 
MDA and concomitantly increased SOD. These 
results strongly suggest that HOL inhibited 





The findings of this study demonstrate that HOL 
possesses good hepatoprotective effects in mice 
with hepatitis jaundice induced by ANIT. The 
potential mechanisms are closely related to 
decreasing SGPT and SGOT, TC, TG, TNF-α 
and MDA, as well as increasing SOD. Thus HOL 
has a potential for development as a treatment 
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